New cancer clinical trial: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Published on: February 08, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share